Phase III trial in orthopedic interventions in 7 sites in Russia started
14 June 2010
OCT started a new trial in orthopedic pain in 7 sites in Russia. The trial was transferred to OCT from another CRO.
OCT Vision
“OCT vision is to be recognized by pharmaceutical and biotech companies as a leading provider of clinical trials in Russia, Ukraine, Bulgaria, Belarus, Latvia, Lithuania, Estonia, Poland and Czech Republic. OCT is able to support any requirements that clients may have in the region, ranging from one-off advice to full-study implementation and execution. We are determined and decisive in expanding our activity at this rapidly growing market”— Dmitry Sharov, General Manager of OCT.
